These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 33388483)

  • 1. The role of the intestinal microbiota in allogeneic HCT: clinical associations and preclinical mechanisms.
    Nguyen CL; Docampo MD; van den Brink MR; Markey KA
    Curr Opin Genet Dev; 2021 Feb; 66():25-35. PubMed ID: 33388483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut microbiota injury in allogeneic haematopoietic stem cell transplantation.
    Shono Y; van den Brink MRM
    Nat Rev Cancer; 2018 May; 18(5):283-295. PubMed ID: 29449660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The contribution of the intestinal microbiome to immune recovery after HCT.
    Wolfe AE; Markey KA
    Front Immunol; 2022; 13():988121. PubMed ID: 36059482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of donor and recipient Epstein-Barr Virus serostatus on outcomes of allogeneic hematopoietic cell transplantation: a systematic review and meta-analysis.
    Kołodziejczak M; Gil L; de la Camara R; Styczyński J;
    Ann Hematol; 2021 Mar; 100(3):763-777. PubMed ID: 33491135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crosstalk Between Intestinal Microbiota Derived Metabolites and Tissues in Allogeneic Hematopoietic Cell Transplantation.
    Fujiwara H
    Front Immunol; 2021; 12():703298. PubMed ID: 34512627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intestinal Microbiota and Relapse After Hematopoietic-Cell Transplantation.
    Peled JU; Devlin SM; Staffas A; Lumish M; Khanin R; Littmann ER; Ling L; Kosuri S; Maloy M; Slingerland JB; Ahr KF; Porosnicu Rodriguez KA; Shono Y; Slingerland AE; Docampo MD; Sung AD; Weber D; Alousi AM; Gyurkocza B; Ponce DM; Barker JN; Perales MA; Giralt SA; Taur Y; Pamer EG; Jenq RR; van den Brink MRM
    J Clin Oncol; 2017 May; 35(15):1650-1659. PubMed ID: 28296584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The intestinal microbiota in allogeneic hematopoietic cell transplant and graft-versus-host disease.
    Staffas A; Burgos da Silva M; van den Brink MR
    Blood; 2017 Feb; 129(8):927-933. PubMed ID: 27940475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical effects and applications of the gut microbiome in hematologic malignancies.
    D'Angelo CR; Sudakaran S; Callander NS
    Cancer; 2021 Mar; 127(5):679-687. PubMed ID: 33369893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update in clinical and mouse microbiota research in allogeneic haematopoietic cell transplantation.
    Lindner S; Peled JU
    Curr Opin Hematol; 2020 Nov; 27(6):360-367. PubMed ID: 33003084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allogeneic hematopoietic cell transplantation, the microbiome, and graft-versus-host disease.
    van Lier YF; Vos J; Blom B; Hazenberg MD
    Gut Microbes; 2023; 15(1):2178805. PubMed ID: 36794370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microbiome-intestine cross talk during acute graft-versus-host disease.
    Rafei H; Jenq RR
    Blood; 2020 Jul; 136(4):401-409. PubMed ID: 32526029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long term survival among patients who are disease free at 1-year post allogeneic hematopoietic cell transplantation: a single center analysis of 389 consecutive patients.
    Solh MM; Bashey A; Solomon SR; Morris LE; Zhang X; Brown S; Holland HK
    Bone Marrow Transplant; 2018 May; 53(5):576-583. PubMed ID: 29335633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of intestinal microbiota in transplantation outcomes.
    Taur Y; Jenq RR; Ubeda C; van den Brink M; Pamer EG
    Best Pract Res Clin Haematol; 2015; 28(2-3):155-61. PubMed ID: 26590773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intestinal microbiota-related effects on graft-versus-host disease.
    Shono Y; Docampo MD; Peled JU; Perobelli SM; Jenq RR
    Int J Hematol; 2015 May; 101(5):428-37. PubMed ID: 25812838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intestinal Microbiota Influence Immune Tolerance Post Allogeneic Hematopoietic Cell Transplantation and Intestinal GVHD.
    Köhler N; Zeiser R
    Front Immunol; 2018; 9():3179. PubMed ID: 30705680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microbiome: An Emerging New Frontier in Graft-Versus-Host Disease.
    Kumari R; Palaniyandi S; Hildebrandt GC
    Dig Dis Sci; 2019 Mar; 64(3):669-677. PubMed ID: 30523482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Gut Colonization by Antibiotic-Resistant Bacteria on the Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective, Single-Center Study.
    Bilinski J; Robak K; Peric Z; Marchel H; Karakulska-Prystupiuk E; Halaburda K; Rusicka P; Swoboda-Kopec E; Wroblewska M; Wiktor-Jedrzejczak W; Basak GW
    Biol Blood Marrow Transplant; 2016 Jun; 22(6):1087-1093. PubMed ID: 26900084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase 2 trial of the somatostatin analog pasireotide to prevent GI toxicity and acute GVHD in allogeneic hematopoietic stem cell transplant.
    Ramalingam S; Siamakpour-Reihani S; Bohannan L; Ren Y; Sibley A; Sheng J; Ma L; Nixon AB; Lyu J; Parker DC; Bain J; Muehlbauer M; Ilkayeva O; Kraus VB; Huebner JL; Spitzer T; Brown J; Peled JU; van den Brink M; Gomes A; Choi T; Gasparetto C; Horwitz M; Long G; Lopez R; Rizzieri D; Sarantopoulos S; Chao N; Sung AD
    PLoS One; 2021; 16(6):e0252995. PubMed ID: 34170918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimating the Lifetime Medical Cost Burden of an Allogeneic Hematopoietic Cell Transplantation Patient.
    Maziarz RT; Devine S; Garrison LP; Agodoa I; Badaracco J; Gitlin M; Perales MA
    Transplant Cell Ther; 2023 Oct; 29(10):637.e1-637.e9. PubMed ID: 37364775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.